Salary: Grade E64: £32,569 - £52,200 p.a.
The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) has an exciting role in the group of Professor Thakker, FRS, for an experienced and qualified clinician to undertake a laboratory based DPhil project identifying novel epigenetic drug targets for pancreatic cancers.
The work will be focused on performing basic science techniques to examine the epigenetic landscape of exocrine and endocrine pancreatic tumours. This will identify common or inverse signatures regulating the expression of proliferation-associated genes that can subsequently be targeted using epigenetic modulating drugs. This role offers the postholder the opportunity to develop an understanding of pancreatic cancer biology, and learn diverse state-of-the-art scientific laboratory techniques, in an academic environment.
The post would suit trainees specialising in endocrinology, oncology, pathology, gastroenterology or endocrine surgery, interested in pursuing a clinical-academic career.
Applicants must be qualified with an MBBS level or equivalent, fully registered with GMC and permitted to practice medicine in the UK. Applicants will ideally have commenced or completed Core Medical Training or a medical specialty equivalent, with MRCP (or equivalent). Motivation to complete a DPhil, excellent communication skills, and the desire to pursue a career in academic medicine are essential for this post.
The post is fixed-term for 3 years full time.
Please quote vacancy number 140696 in all correspondence.
Only applications received before 12.00 midday on 4 June 2019 can be considered.